JPMorgan Chase & Co. Has $9.22 Million Stake in Adient plc (NYSE:ADNT)

JPMorgan Chase & Co. decreased its position in shares of Adient plc (NYSE:ADNT - Free Report) by 31.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 408,429 shares of the company's stock after selling 183,852 shares during the quarter. JPMorgan Chase & Co. owned about 0.48% of Adient worth $9,218,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the company. Pacer Advisors Inc. raised its holdings in Adient by 38,074.9% during the 3rd quarter. Pacer Advisors Inc. now owns 5,144,445 shares of the company's stock worth $116,110,000 after buying an additional 5,130,969 shares during the period. Pzena Investment Management LLC lifted its position in Adient by 45.0% in the 3rd quarter. Pzena Investment Management LLC now owns 2,825,491 shares of the company's stock valued at $63,771,000 after acquiring an additional 877,142 shares in the last quarter. D. E. Shaw & Co. Inc. boosted its stake in Adient by 86.3% in the 2nd quarter. D. E. Shaw & Co. Inc. now owns 1,133,901 shares of the company's stock worth $28,019,000 after purchasing an additional 525,280 shares during the period. Hotchkis & Wiley Capital Management LLC increased its holdings in Adient by 9.3% during the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 5,197,090 shares of the company's stock worth $117,298,000 after purchasing an additional 442,200 shares in the last quarter. Finally, Empowered Funds LLC bought a new stake in shares of Adient in the third quarter valued at about $6,653,000. Institutional investors and hedge funds own 92.44% of the company's stock.

Adient Stock Performance

NYSE ADNT traded up $0.29 during trading on Tuesday, reaching $17.39. The company's stock had a trading volume of 1,139,888 shares, compared to its average volume of 1,056,911. The firm has a 50 day moving average price of $18.63 and a 200 day moving average price of $21.11. Adient plc has a 12 month low of $16.28 and a 12 month high of $36.04. The firm has a market capitalization of $1.48 billion, a price-to-earnings ratio of 75.61, a price-to-earnings-growth ratio of 0.32 and a beta of 2.16. The company has a current ratio of 1.11, a quick ratio of 0.90 and a debt-to-equity ratio of 0.98.

Adient (NYSE:ADNT - Get Free Report) last posted its quarterly earnings data on Friday, November 8th. The company reported $0.68 EPS for the quarter, topping analysts' consensus estimates of $0.56 by $0.12. The firm had revenue of $3.56 billion for the quarter, compared to analyst estimates of $3.47 billion. Adient had a return on equity of 6.86% and a net margin of 0.12%. The company's revenue was down 3.7% on a year-over-year basis. During the same quarter last year, the company earned $0.51 EPS. As a group, equities analysts anticipate that Adient plc will post 2.04 EPS for the current fiscal year.

Insider Activity

In related news, EVP James Conklin sold 11,500 shares of the business's stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $20.25, for a total transaction of $232,875.00. Following the sale, the executive vice president now owns 51,829 shares in the company, valued at $1,049,537.25. The trade was a 18.16 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 1.30% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have issued reports on ADNT shares. StockNews.com raised shares of Adient from a "hold" rating to a "buy" rating in a research report on Saturday, December 28th. Morgan Stanley cut their target price on shares of Adient from $21.00 to $19.00 and set an "underweight" rating for the company in a research note on Thursday, November 14th. Wells Fargo & Company cut Adient from an "overweight" rating to an "equal weight" rating and cut their price objective for the company from $27.00 to $20.00 in a research report on Monday, December 16th. Finally, Bank of America lowered Adient from a "buy" rating to a "neutral" rating and decreased their target price for the stock from $30.00 to $24.00 in a report on Thursday, November 21st. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $23.50.

Adient Profile

Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.